Home » Stocks » POAI

Predictive Oncology Inc. (POAI)

Stock Price: $0.985 USD -0.025 (-2.50%)
Updated Jun 21, 2021 12:59 PM EDT - Market open
Market Cap 50.32M
Revenue (ttm) 1.24M
Net Income (ttm) -25.80M
Shares Out 36.51M
EPS (ttm) -1.30
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 21
Last Price $0.985
Previous Close $1.010
Change ($) -0.025
Change (%) -2.50%
Day's Open 1.010
Day's Range 0.935 - 1.020
Day's Volume 1,980,269
52-Week Range 0.630 - 2.300

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Making a penny stocks watchlist for July? Check these 7 out The post Hot Penny Stocks to Buy Right Now?

Other stocks mentioned: GTE, JOB, LLNW, METX, QD, ZOM
2 days ago - PennyStocks

MINNEAPOLIS, June 18, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“...

3 days ago - GlobeNewsWire

Are these Robinhood penny stocks the best to watch in 2021? The post Best Penny Stocks to Buy on Robinhood?

Other stocks mentioned: ADMP, SOLO
4 days ago - PennyStocks

Looking for well-funded biotech penny stocks? Check these 3 small-caps out The post Best Biotech Penny Stocks to Buy?

Other stocks mentioned: APRE, ITRM
4 days ago - PennyStocks

MINNEAPOLIS, June 14, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“...

1 week ago - GlobeNewsWire

These four penny stocks could get a huge boost from the success of the underlying companies' AI systems going forward. The post 4 Penny Stocks With the Potential to Become Top-Notch AI Players appeared ...

Other stocks mentioned: INOD, LAIX, MARK
2 weeks ago - InvestorPlace

MINNEAPOLIS, June 02, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discove...

2 weeks ago - GlobeNewsWire

MINNEAPOLIS, May 20, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), an artificial intelligence driven oncology and drug discovery company, announced today that its wholly owned subsidiary,...

1 month ago - GlobeNewsWire

MINNEAPOLIS, May 12, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug dis...

1 month ago - GlobeNewsWire

MINNEAPOLIS, April 27, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discov...

1 month ago - GlobeNewsWire

MINNEAPOLIS, March 23, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence to personalized medicine and drug discovery, is...

2 months ago - GlobeNewsWire

MINNEAPOLIS, March 15, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) – Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to ...

3 months ago - GlobeNewsWire

Helomics Researchers Complete Key Sequencing Milestones and Focus on AI-Driven Model Building Helomics Researchers Complete Key Sequencing Milestones and Focus on AI-Driven Model Building

3 months ago - GlobeNewsWire

MINNEAPOLIS, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“...

3 months ago - GlobeNewsWire

MINNEAPOLIS, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discove...

4 months ago - GlobeNewsWire

MINNEAPOLIS, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“...

4 months ago - GlobeNewsWire

MINNEAPOLIS, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“...

4 months ago - GlobeNewsWire

MINNEAPOLIS, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discove...

4 months ago - GlobeNewsWire

MINNEAPOLIS, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“...

4 months ago - GlobeNewsWire

MINNEAPOLIS, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“...

4 months ago - GlobeNewsWire

MINNEAPOLIS, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“...

4 months ago - GlobeNewsWire

MINNEAPOLIS, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“...

4 months ago - GlobeNewsWire

EAGAN, Minn., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discov...

5 months ago - GlobeNewsWire

MINNEAPOLIS, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“...

5 months ago - GlobeNewsWire

MINNEAPOLIS, Jan. 08, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“...

5 months ago - GlobeNewsWire

Our new PeDAL fee-for-service offering for Pharmaceutical companies will significantly improve the chances of translating discoveries into the clinic Our new PeDAL fee-for-service offering for Pharmaceu...

5 months ago - GlobeNewsWire

MINNEAPOLIS, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discove...

5 months ago - GlobeNewsWire

Reincorporation Proposal Received Overwhelming Support Among Shares Voted Reincorporation Proposal Received Overwhelming Support Among Shares Voted

5 months ago - GlobeNewsWire

NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery,...

6 months ago - GlobeNewsWire

NEW YORK, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery,...

7 months ago - GlobeNewsWire

NEW YORK, Oct. 27, 2020 (GLOBE NEWSWIRE) -- via NetworkNewsAudio — Predictive Oncology Inc. (NASDA Q : POAI) today announces that its chief executive officer, Carl Schwartz, has been featured in an excl...

7 months ago - GlobeNewsWire

EAGAN, Minn., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ:POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discove...

8 months ago - GlobeNewsWire

Predictive Oncology now has a total of 96 unique Patient Derived Cells (PDCs) from Ovarian Cancer Patients. Predictive Oncology now has a total of 96 unique Patient Derived Cells (PDCs) from Ovarian Can...

8 months ago - GlobeNewsWire

EAGAN, Minn., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug dis...

9 months ago - GlobeNewsWire

EAGAN, Minn., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug disc...

10 months ago - GlobeNewsWire

EAGAN, Minn., Aug. 18, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug disc...

10 months ago - GlobeNewsWire

LOS ANGELES, Aug. 14, 2020 (GLOBE NEWSWIRE) -- via NetworkWire — Predictive Oncology Inc. (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalize...

10 months ago - GlobeNewsWire

Increases Readiness for Commercialization with Expanded Portfolio of Solutions for Precision Medicine

10 months ago - GlobeNewsWire

Annual Meeting of Stockholders to be Held on September 3, 2020 Annual Meeting of Stockholders to be Held on September 3, 2020

10 months ago - GlobeNewsWire

Adds Industry, Business Development and Financial Expertise Adds Industry, Business Development and Financial Expertise

11 months ago - GlobeNewsWire

Acquisition Focused on Accelerating Commercialization of AI-driven Drug Discovery and Development Acquisition Focused on Accelerating Commercialization of AI-driven Drug Discovery and Development

11 months ago - GlobeNewsWire

MINNEAPOLIS, June 29, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (the “Company,” “Predictive Oncology,” “we,” “our” or “us”) (NASDAQ: POAI), a knowledge-driven company focused on applying artif...

11 months ago - GlobeNewsWire

A Top US Medical Institution Places the First Commercial Order for the Media used to grow Ovarian Cancer Cell Types that are Exceedingly Difficult to Grow and Retain the Signatures of the Patient Derive...

1 year ago - GlobeNewsWire

CancerQuest 2020 Study on Schedule for Completion in Q2 2020 CancerQuest 2020 Study on Schedule for Completion in Q2 2020

1 year ago - GlobeNewsWire

MINNEAPOLIS, June 02, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (the “Company”) a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized med...

1 year ago - GlobeNewsWire

MINNEAPOLIS, May 14, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI)  has, with the announced acquisition of Soluble Therapeutics and the subsequent partnership and licensing of a novel na...

1 year ago - GlobeNewsWire

MINNEAPOLIS, May 07, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (...

1 year ago - GlobeNewsWire

MINNEAPOLIS, May 06, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) has, with the announced acquisition of Soluble Therapeutics, Inc. and the subsequent partnership and licensing of a nov...

1 year ago - GlobeNewsWire

CEO Agrees to Exchange $2.1 Million Promissory Note for Newly Issued Equity, Demonstrating Confidence in Company’s Future CEO Agrees to Exchange $2.1 Million Promissory Note for Newly Issued Equity, Dem...

1 year ago - GlobeNewsWire

NEW YORK, April 22, 2020 (GLOBE NEWSWIRE) -- via NetworkNewsAudio — Predictive Oncology (NASDAQ: POAI) today announces that Company director and CEO Dr. Carl Schwartz, in an interview with NetworkNew...

1 year ago - GlobeNewsWire

About POAI

Predictive Oncology Inc. provides various healthcare products and services primarily in the United States. The company operates in three segments: Helomics, Soluble, and Skyline. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers STREAMWAY System, a wall-mounted fully automated system that disposes suction fluid providing uninterrupted performance for physicians while virtually eliminating healthcare workers' expo... [Read more...]

Industry
Medical Instruments & Supplies
Founded
2002
CEO
Joshua Kornberg
Employees
22
Stock Exchange
NASDAQ
Ticker Symbol
POAI
Full Company Profile

Financial Performance

In 2020, POAI's revenue was $1.25 million, a decrease of -11.28% compared to the previous year's $1.41 million. Losses were -$25.88 million, 33.5% more than in 2019.

Financial Statements